1 |
Cyclophosphamide
| 1件: Cyclophosphamide Cyclophosphamide | 6件: Ciclofosfamida Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamidum; Cytoxan; | - | - | 44件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 |
2 |
Desmopressin
| 1件: Desmopressin Desmopressin | 5件: DDAVP DDAVP; Desmopressin; Desmopressin Acetate; Desmopressine; Minirin; | 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 6件: 6 6, 64, 72, 75, 225, 288 |
3 |
Simvastatin
| 1件: Simvastatin Simvastatin | 3件: Simvastatin Simvastatin; Simvastatina; Simvastatine; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 21件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
4 |
Prednisone
| 1件: Prednisone Prednisone | 3件: PREDNISONA PREDNISONA; PREDNISONE; RAYOS; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 |
5 |
Tranexamic acid
| 1件: Tranexamic acid Tranexamic acid | 1件: Tranexamic acid Tranexamic acid; | 1件: PLG PLG 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 7件: 46 46, 70, 215, 227, 274, 288, 299 |
6 |
Sodium chloride
| 1件: Sodium chloride Sodium chloride | 6件: Lactated Ringers Lactated Ringers; Natriumchlorid; REBIF; Saline; Sodium chloride; Sporanox; | - | - | 20件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 |
7 |
Rituximab
| 1件: Rituximab Rituximab | 6件: MabThera MabThera; Rituxan; RITUXIMAB; Rixathon; Ruxience; Truxima; | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
8 |
Bortezomib
| 1件: Bortezomib Bortezomib | 3件: BORTEZOMIB BORTEZOMIB; Bortezomib Accord; Velcade; | 1件: PSMB5 PSMB5 💬 | 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 17件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 |
9 |
Oprelvekin
| 1件: Oprelvekin Oprelvekin | 5件: IL-11 IL-11; Interleukin 11; Interleukin-11; Oprelvekin; Recombinant interleukin-11; | 1件: IL11RA IL11RA 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | 2件: 96 96, 288 |
10 |
Cyclophosphamide
| 1件: Cyclophosphamide Cyclophosphamide | 6件: Ciclofosfamida Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamidum; Cytoxan; | - | - | 44件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 |
11 |
Vonicog alfa
| 1件: Vonicog alfa Vonicog alfa | 3件: Veyvondi Veyvondi; VON WILLEBRAND FACTOR; VONICOG ALFA; | - | - | 1件: 288 288 |
12 |
Catridecacog
| 1件: Catridecacog Catridecacog | 1件: Catridecacog Catridecacog; | - | - | 2件: 97 97, 288 |
13 |
Rurioctocog alfa pegol
| 1件: Rurioctocog alfa pegol Rurioctocog alfa pegol | 1件: Rurioctocog alfa pegol Rurioctocog alfa pegol; | - | - | 1件: 288 288 |
14 |
Emicizumab
| 1件: Emicizumab Emicizumab | 2件: Emicizumab Emicizumab; Hemlibra; | 2件: F10 F10, F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
15 |
Susoctocog alfa
| 1件: Susoctocog alfa Susoctocog alfa | 1件: OBIZUR OBIZUR; | - | - | 1件: 288 288 |
16 |
Efanesoctocog alfa
| 1件: Efanesoctocog alfa Efanesoctocog alfa | 1件: Efanesoctocog alfa Efanesoctocog alfa; | - | - | 1件: 288 288 |